Skip to main content

Acquired Hyperpigmentation Disorders of Uncertain Etiology

  • Chapter
  • First Online:
New and Emerging Entities in Dermatology and Dermatopathology

Abstract

This chapter is a compilation of a few uncommon, hyperpigmented enigmatic dermatoses of unclear etiology that are difficult to diagnose and treat. They include lichen planus pigmentosus, erythema dyschromicum perstans, ashy dermatosis, idiopathic eruptive macular pigmentation, and acquired brachial cutaneous dyschromatosis. Most of them are more prevalent in Latin America or India as they usually involve patients with Fitzpatrick skin type IV and V. These dermatoses when present in dark-skinned population have a tremendous psychological impact and are often a sociocultural setback for the patients because pigmentary dermatoses are a bane of the colored population. As a result, they desperately seek treatment ranging from self-treatment with steroid-containing creams to home remedies to treatments offered by general practitioners, many of whom are not even qualified to treat. The financial impact of these treatments is significant as well as the impact on the quality of life due to the chronic nature of these diseases. Also, many of these conditions are mired in taxonomical confusion due to their similarity on several counts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bhutani LK, Bedi TR, Pandhi RK, Nayak NC. Lichen planus pigmentosus. Dermatologica. 1974;149(1):43–50. https://doi.org/10.1159/000251470. PMID: 4154221.

    Article  CAS  PubMed  Google Scholar 

  2. Kanwar AJ, Dogra S, Handa S, Parsad D, Radotra BD. A study of 124 Indian patients with lichen planus pigmentosus. Clin Exp Dermatol. 2003;28(5):481–5. https://doi.org/10.1046/j.1365-2230.2003.01367.x. PMID: 12950331.

    Article  CAS  PubMed  Google Scholar 

  3. Robles-Méndez JC, Rizo-Frías P, Herz-Ruelas ME, Pandya AG, Ocampo CJ. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57(5):505–14.

    Article  Google Scholar 

  4. Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D. A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis. Int J Dermatol. 2019;58(3):263–72.

    Article  Google Scholar 

  5. Mendiratta V, Sanke S, Chander R. Lichen planus Pigmentosus: a Clinico-etiological study. Indian Dermatol Online J. 2019;10(3):288–92.

    Article  Google Scholar 

  6. Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. 2010;24(5):535–40. https://doi.org/10.1111/j.1468-3083.2009.03460.x. Epub 2009 Oct 15. PMID: 19840200.

    Article  CAS  PubMed  Google Scholar 

  7. Pirmez R, Duque-Estrada B, Donati A, Campos-do-Carmo G, Valente NS, Romiti R, Sodré CT, Tosti A. Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia. Br J Dermatol. 2016;175(6):1387–90. https://doi.org/10.1111/bjd.14722. Epub 2016 Oct 23. PMID: 27233640.

    Article  CAS  PubMed  Google Scholar 

  8. Kim JE, Won CH, Chang S, et al. Linear lichen planus pigmentosus of the forehead treated by neodymium: yttrium aluminum- garnet laser and topical tacrolimus. J Dermatol. 2012;39:189–91.

    Article  Google Scholar 

  9. Sindhura KB, Vinay K, Kumaran MS, et al. Lichen planus pigmentosus: a retrospective clinico-epidemiologic study with emphasis on the rare follicular variant. J Eur Acad Dermatol Venereol. 2015;30:e142–4.

    Article  Google Scholar 

  10. Verma P, Pandhi D. Topical tacrolimus and oral dapsone combination regimen in lichen planus pigmentosus. Skinmed. 2015;13:351–4.

    PubMed  Google Scholar 

  11. Muthu SK, Narang T, Saikia UN, et al. Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol. 2016;55:1048–54.

    Article  CAS  Google Scholar 

  12. Vinay K, Kumar S, Bishnoi A, Aggarwal D, Radotra BD, Parsad D, Sendhil KM. A clinico-demographic study of 344 patients with lichen planus pigmentosus seen in a tertiary care center in India over an 8-year period. Int J Dermatol. 2020;59(2):245–52. https://doi.org/10.1111/ijd.14540. Epub 2019 Jun 23. PMID: 31231800.

    Article  PubMed  Google Scholar 

  13. Ramirez CO. The ashy dermatosis (erythema dyschromicum perstans). Epidemiological study and report of 139 cases. Cutis. 1967;3:244–7.

    Google Scholar 

  14. Convit J, Kerdel-Vegas F, Rodriguez G. Erythema dyschromicum perstans. A hitherto undescribed skin disease. J Invest Dermatol. 1961;36:457–65.

    Article  Google Scholar 

  15. Torrelo A, Zaballos P, Colmenero I, et al. Erythema dyschromicum perstans in children: a report of 14 cases. J Eur Acad Dermatol Venereol. 2005;19:422–6.

    Article  Google Scholar 

  16. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18:91–8.

    Article  CAS  Google Scholar 

  17. Udompanich S, Vachiramon V. Acquired macular pigmentation of unknown etiology. J Clin Aesthet Dermatol. 2019;12(1):38–46. Epub 2019 Jan 1. PMID: 30881577; PMCID: PMC6405250.

    PubMed  PubMed Central  Google Scholar 

  18. Imanishi H, Tsuruta D, Kobayashi H, et al. Two cases of unilateral ashy dermatosis. Case Rep Dermatol. 2011;3:1–4. 38

    Article  Google Scholar 

  19. Chang SE, Kim HW, Shin JM, Lee JH, Na JI, Roh MR, Lee JH, Lee GY, Ko JY. Clinical and histological aspect of erythema dyschromicum perstans in Korea: a review of 68 cases. J Dermatol. 2015;42(11):1053–7. https://doi.org/10.1111/1346-8138.13002. Epub 2015 Jun 29. PMID: 26118942.

    Article  PubMed  Google Scholar 

  20. Kontochristopoulos GJ, Aroni K, Anagnostopoulos G, et al. Erythema dyschromicum perstans and hepatitis C virus infection. Int J Dermatol. 2001;40:346–8.

    Article  CAS  Google Scholar 

  21. Melo CRF, Sa MC, Carvalho S. Erythema dyschromicum perstans in a child following an enteroviral meningitis. An Bras Dermatol. 2017;92:137–8.

    Article  Google Scholar 

  22. Venencie PY, Lemay D, Verroust F. Erythema dyschromicum perstans following human immunodeficiency virus seroconversion in a child with hemophilia B. Arch Dermatol. 1988;124:1013–4.

    Article  CAS  Google Scholar 

  23. Correa MC, Memije EV, Vargas-Alarcon G, et al. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican mestizo patients. J Am Acad Dermatol. 2007;56:617–20.

    Article  Google Scholar 

  24. Vasquez-Ochoa LA, Isaza-Guzman DM, Orozco-Mora B, et al. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis). Int J Dermatol. 2006;45:937–41.

    Article  Google Scholar 

  25. Li S, Arvisais-Anhalt S, Vandergriff T, Le LQ. Ashy dermatosis-like hyperpigmentation in a patient taking hydroxyurea. JAAD Case Rep. 2020;6(9):797–800. https://doi.org/10.1016/j.jdcr.2020.06.030. PMID: 32875022; PMCID: PMC7452229.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tienthavorn T, Tresukosol P, Sudtikoonaseth P. Patch testing and histopathology in Thai patients with hyperpigmentation due to erythema dyschromicum perstans, lichen planus pigmentosus, and pigmented contact dermatitis. Asian Pac J Allergy Immunol. 2014;32:185–92.

    PubMed  Google Scholar 

  27. Mahajan VK, Chauhan PS, Mehta KS, et al. Erythema dyschromicum perstans: response to topical tacrolimus. Indian J Dermatol. 2015;60:525.

    Article  Google Scholar 

  28. Bahadir S, Cobanoglu U, Cimsit G, et al. Erythema dyschromicum perstans: response to dapsone therapy. Int J Dermatol. 2004;43:220–2.

    Article  Google Scholar 

  29. Wang F, Zhao YK, Wang Z, et al. Erythema dyschromicum perstans: response to isotretinoin. JAMA Dermatol. 2016;152:841–2.

    Article  Google Scholar 

  30. Degos R, Civatte J, Belaich S. La pigmentation maculeuse eruptive idiopathique. Ann Dermatol Venereol. 1978;105:177–82.

    CAS  PubMed  Google Scholar 

  31. Sanz de Galdeano C, Leaute-Labreze C, Bioulac-Sage P, et al. Idiopathic eruptive macular pigmentation: report of 5 patients. Pediatr Dermatol. 1996;13:274–7.

    Article  CAS  Google Scholar 

  32. Joshi R, Palwade PK. Idiopathic eruptive macular pigmentation or acanthosis nigricans? Indian J Dermatol Venereol Leprol. 2010;76:591.

    Article  Google Scholar 

  33. Rongioletti F, Rebora A. Acquired brachial cutaneous dyschromatosis: a common pigmentary disorder of the arm in middle-aged women. J Am Acad Dermatol. 2000;42:680–4.

    Article  CAS  Google Scholar 

  34. Hu SW, Chu J, Meehan S, Kamino H, et al. Acquired brachial cutaneous dyschromatosis. Dermatol Online J. 2011;17:16.

    PubMed  Google Scholar 

  35. Abidi N, Foering K, Sahu J. Acquired brachial cutaneous dyschromatosis in a 60-year-old male: a case report and review of the literature. Case Rep Dermatol Med. 2014;2014:452720.

    PubMed  PubMed Central  Google Scholar 

  36. Choi MJ, Byun JY, Choi HY, et al. Acquired brachial cutaneous Dyschromatosis in a middle aged Malle. Ann Dermatol. 2018;30(3):342–4.

    Article  Google Scholar 

  37. Ritter CG, Fiss DVC, da Borges Costa JAT, et al. Extra-facial melasma: clinical, histopathological, and Immunohistochemical Case-Control Study. J Eur Acad Dermatol Venereol. 2013;27(9):1088–94.

    Article  CAS  Google Scholar 

  38. O’brien TJ, Dyall-Smith D, Hall AP. Melasma of the forearms. Austr J Dermatol. 1997;38:35–7.

    Article  Google Scholar 

  39. Park JH, Lee DJ, Lee YJ, et al. Acquired bilateral telangiectatic macules: a distinct clinical entity. JAMA Dermatol. 2014;150:974–7.

    Article  Google Scholar 

  40. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2:253–62.

    Article  CAS  Google Scholar 

  41. Hayashi M, Suzuki T. Dyschromatosis symmetrica hereditaria. J Dermatol. 2013;40(5):336–43.

    Article  CAS  Google Scholar 

  42. Picardo M, Carrera M. New and experimental treatments of cloasma and other hypermelanoses. Dermatol Clin. 2007;25(3):353–ix. https://doi.org/10.1016/j.det.2007.04.012.

    Article  CAS  PubMed  Google Scholar 

  43. Tierney EP, Hanke CW. Review of the literature: treatment of dyspigmentation with fractionated resurfacing. Dermatol Surg. 2010;36(10):1499–508.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Poojary, S., Rongioletti, F. (2021). Acquired Hyperpigmentation Disorders of Uncertain Etiology. In: Rongioletti, F., Smoller, B.R. (eds) New and Emerging Entities in Dermatology and Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-80027-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80027-7_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80026-0

  • Online ISBN: 978-3-030-80027-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics